Associations between obesity, a composite risk score for probable long COVID, and sleep problems in SARS-CoV-2 vaccinated individuals.
Journal
International journal of obesity (2005)
ISSN: 1476-5497
Titre abrégé: Int J Obes (Lond)
Pays: England
ID NLM: 101256108
Informations de publication
Date de publication:
07 Jun 2024
07 Jun 2024
Historique:
received:
16
08
2023
accepted:
24
05
2024
revised:
22
05
2024
medline:
8
6
2024
pubmed:
8
6
2024
entrez:
7
6
2024
Statut:
aheadofprint
Résumé
Preliminary data suggests that obesity might hasten the decline in mRNA vaccine-induced immunity against SARS-CoV-2. However, whether this renders individuals with obesity more susceptible to long COVID symptoms post-vaccination remains uncertain. Given sleep's critical role in immunity, exploring the associations between obesity, probable long COVID symptoms, and sleep disturbances is essential. We analyzed data from a survey of 5919 adults aged 18 to 89, all of whom received two SARS-CoV-2 mRNA vaccinations. Participants were categorized into normal weight, overweight, and obesity groups based on ethnicity-specific BMI cutoffs. The probability of long COVID was evaluated using the Post-Acute Sequelae of SARS-CoV-2 (PASC) score, as our survey did not permit confirmation of acute SARS-CoV-2 infection through methods such as antibody testing. Additionally, sleep patterns were assessed through questionnaires. Participants with obesity exhibited a significantly higher adjusted odds ratio (OR) of having a PASC score of 12 or higher, indicative of probable long COVID in our study, compared to those with normal weight (OR: 1.55, 95% CI: 1.05, 2.28). No significant difference was observed for overweight individuals (OR: 0.92 [95% CI: 0.63, 1.33]). Both obesity and probable long COVID were associated with increased odds of experiencing a heightened sleep burden, such as the presence of obstructive sleep apnea or insomnia (P < 0.001). However, no significant interaction between BMI and probable long COVID status was found. Even post-vaccination, individuals with obesity may encounter a heightened risk of experiencing prolonged COVID-19 symptoms. However, confirming our observations necessitates comprehensive studies incorporating rigorous COVID infection testing, such as antibody assays - unavailable in our anonymous survey. Additionally, it is noteworthy that the correlation between probable long COVID and sleep disturbances appears to be independent of BMI.
Sections du résumé
BACKGROUND
BACKGROUND
Preliminary data suggests that obesity might hasten the decline in mRNA vaccine-induced immunity against SARS-CoV-2. However, whether this renders individuals with obesity more susceptible to long COVID symptoms post-vaccination remains uncertain. Given sleep's critical role in immunity, exploring the associations between obesity, probable long COVID symptoms, and sleep disturbances is essential.
METHODS
METHODS
We analyzed data from a survey of 5919 adults aged 18 to 89, all of whom received two SARS-CoV-2 mRNA vaccinations. Participants were categorized into normal weight, overweight, and obesity groups based on ethnicity-specific BMI cutoffs. The probability of long COVID was evaluated using the Post-Acute Sequelae of SARS-CoV-2 (PASC) score, as our survey did not permit confirmation of acute SARS-CoV-2 infection through methods such as antibody testing. Additionally, sleep patterns were assessed through questionnaires.
RESULTS
RESULTS
Participants with obesity exhibited a significantly higher adjusted odds ratio (OR) of having a PASC score of 12 or higher, indicative of probable long COVID in our study, compared to those with normal weight (OR: 1.55, 95% CI: 1.05, 2.28). No significant difference was observed for overweight individuals (OR: 0.92 [95% CI: 0.63, 1.33]). Both obesity and probable long COVID were associated with increased odds of experiencing a heightened sleep burden, such as the presence of obstructive sleep apnea or insomnia (P < 0.001). However, no significant interaction between BMI and probable long COVID status was found.
CONCLUSIONS
CONCLUSIONS
Even post-vaccination, individuals with obesity may encounter a heightened risk of experiencing prolonged COVID-19 symptoms. However, confirming our observations necessitates comprehensive studies incorporating rigorous COVID infection testing, such as antibody assays - unavailable in our anonymous survey. Additionally, it is noteworthy that the correlation between probable long COVID and sleep disturbances appears to be independent of BMI.
Identifiants
pubmed: 38849462
doi: 10.1038/s41366-024-01556-w
pii: 10.1038/s41366-024-01556-w
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
© 2024. The Author(s).
Références
Coronavirus disease (COVID-19). https://www.who.int/news-room/fact-sheets/detail/coronavirus-disease-(covid-19) ; date of retrieval: 24/05/24
Chen C, Haupert SR, Zimmermann L, Shi X, Fritsche LG, Mukherjee B. Global prevalence of post-Coronavirus Disease 2019 (COVID-19) condition or long COVID: a meta-analysis and systematic review. J Infect Dis. 2022;226:1593–607.
doi: 10.1093/infdis/jiac136
pubmed: 35429399
Gottlieb RL, Vaca CE, Paredes R, Mera J, Webb BJ, Perez G, et al. Early remdesivir to prevent progression to severe Covid-19 in outpatients. N Engl J Med. 2022;386:305–15.
doi: 10.1056/NEJMoa2116846
pubmed: 34937145
Doria-Rose N, Suthar MS, Makowski M, O’Connell S, McDermott AB, Flach B, et al. Antibody persistence through 6 months after the second dose of mRNA-1273 vaccine for Covid-19. N Engl J Med. 2021;384:2259–61.
doi: 10.1056/NEJMc2103916
pubmed: 33822494
pmcid: 8524784
Mohammed I, Nauman A, Paul P, Ganesan S, Chen KH, Jalil SMS, et al. The efficacy and effectiveness of the COVID-19 vaccines in reducing infection, severity, hospitalization, and mortality: a systematic review. Hum Vaccin Immunother. 2022;18:2027160.
doi: 10.1080/21645515.2022.2027160
pubmed: 35113777
pmcid: 8862168
Ayoubkhani D, Bermingham C, Pouwels KB, Glickman M, Nafilyan V, Zaccardi F, et al. Trajectory of long covid symptoms after covid-19 vaccination: community based cohort study. BMJ. 2022;377:e069676.
doi: 10.1136/bmj-2021-069676
pubmed: 35584816
Kompaniyets L, Agathis NT, Nelson JM, Preston LE, Ko JY, Belay B, et al. Underlying Medical Conditions Associated With Severe COVID-19 Illness Among Children. JAMA Netw Open. 2021;4:e2111182.
doi: 10.1001/jamanetworkopen.2021.11182
pubmed: 34097050
pmcid: 8185607
Luo J, Zhang J, Tang HT, Wong HK, Lyu A, Cheung CH, et al. Prevalence and risk factors of long COVID 6-12 months after infection with the Omicron variant among nonhospitalized patients in Hong Kong. J Med Virol. 2023;95:e28862.
doi: 10.1002/jmv.28862
pubmed: 37334978
Loosen SH, Jensen BO, Tanislav C, Luedde T, Roderburg C, Kostev K. Obesity and lipid metabolism disorders determine the risk for development of long COVID syndrome: a cross-sectional study from 50,402 COVID-19 patients. Infection. 2022;50:1165–70.
doi: 10.1007/s15010-022-01784-0
pubmed: 35355237
pmcid: 8966865
Heubner L, Petrick PL, Güldner A, Bartels L, Ragaller M, Mirus M, et al. Extreme obesity is a strong predictor for in-hospital mortality and the prevalence of long-COVID in severe COVID-19 patients with acute respiratory distress syndrome. Sci Rep. 2022;12:18418.
doi: 10.1038/s41598-022-22107-1
pubmed: 36319681
pmcid: 9626466
Vimercati L, De Maria L, Quarato M, Caputi A, Gesualdo L, Migliore G, et al. Association between long COVID and overweight/obesity. J Clin Med. 2021;10:4143.
doi: 10.3390/jcm10184143
pubmed: 34575251
pmcid: 8469321
van der Klaauw AA, Horner EC, Pereyra-Gerber P, Agrawal U, Foster WS, Spencer S, et al. Accelerated waning of the humoral response to COVID-19 vaccines in obesity. Nat Med. 2023;29:1146–54.
doi: 10.1038/s41591-023-02343-2
pubmed: 37169862
pmcid: 10202802
Thaweethai T, Jolley SE, Karlson EW, Levitan EB, Levy B, McComsey GA, et al. Development of a definition of postacute sequelae of SARS-CoV-2 Infectio. JAMA. 2023;329:1934–1946.
doi: 10.1001/jama.2023.8823
pubmed: 37278994
pmcid: 10214179
Davis HE, McCorkell L, Vogel JM, Topol EJ. Long COVID: major findings, mechanisms and recommendations. Nat Rev Microbiol. 2023;21:133–46.
doi: 10.1038/s41579-022-00846-2
pubmed: 36639608
pmcid: 9839201
Pearson NJ, Johnson LL, Nahin RL. Insomnia, trouble sleeping, and complementary and alternative medicine: Analysis of the 2002 national health interview survey data. Arch Intern Med. 2006;166:1775–82.
doi: 10.1001/archinte.166.16.1775
pubmed: 16983058
Gami AS, Caples SM, Somers VK. Obesity and obstructive sleep apnea. Endocrinol Metab Clin North Am. 2003;32:869–94.
doi: 10.1016/S0889-8529(03)00069-0
pubmed: 14711066
van den Berg JF, Knvistingh Neven A, Tulen JH, Hofman A, Witteman JC, Miedema HM, et al. Actigraphic sleep duration and fragmentation are related to obesity in the elderly: the Rotterdam Study. Int J Obes (Lond). 2008;32:1083–90.
doi: 10.1038/ijo.2008.57
pubmed: 18414418
Besedovsky L, Lange T, Born J. Sleep and immune function. Pflugers Arch. 2012;463:121–37.
doi: 10.1007/s00424-011-1044-0
pubmed: 22071480
Spiegel K, Rey AE, Cheylus A, Ayling K, Benedict C, Lange T, et al. A meta-analysis of the associations between insufficient sleep duration and antibody response to vaccination. Curr Biol. 2023;33:998–1005.e2.
doi: 10.1016/j.cub.2023.02.017
pubmed: 36917932
Izuhara M, Matsui K, Yoshiike T, Kawamura A, Utsumi T, Nagao K, et al. Association between sleep duration and antibody acquisition after mRNA vaccination against SARS-CoV-2. Front Immunol. 2023;14:1242302.
doi: 10.3389/fimmu.2023.1242302
pubmed: 38149250
pmcid: 10750410
Lin YN, Zhou LN, Liu ZR, Wang Y, Li SQ, Lu FY, et al. Short sleep duration is associated with prolonged virus shedding in SARS-CoV-2 omicron-infected patients. Nat Sci Sleep. 2023;15:547–54.
doi: 10.2147/NSS.S411677
pubmed: 37441268
pmcid: 10335320
Xue P, Merikanto I, Chung F, Morin CM, Espie C, Bjorvatn B, et al. Persistent short nighttime sleep duration is associated with a greater post-COVID risk in fully mRNA-vaccinated individuals. Transl Psychiatry. 2023;13:32.
doi: 10.1038/s41398-023-02334-4
pubmed: 36726008
pmcid: 9890416
Athanasiou N, Baou K, Papandreou E, Varsou G, Amfilochiou A, Kontou E, et al. Association of sleep duration and quality with immunological response after vaccination against severe acute respiratory syndrome coronavirus-2 infection. J Sleep Res. 2023;32:e13656.
doi: 10.1111/jsr.13656
pubmed: 35670298
Merikanto I, Dauvilliers Y, Chung F, Wing YK, De Gennaro L, Holzinger B, et al. Sleep symptoms are essential features of long-COVID - Comparing healthy controls with COVID-19 cases of different severity in the international COVID sleep study (ICOSS-II). J Sleep Res. 2023;32:e13754.
doi: 10.1111/jsr.13754
pubmed: 36208038
Expert Consultation WHO. Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet. 2004;363:157–63.
doi: 10.1016/S0140-6736(03)15268-3
Pérez-Carbonell L, Mignot E, Leschziner G, Dauvilliers Y. Understanding and approaching excessive daytime sleepiness. Lancet. 2022;400:1033–46.
doi: 10.1016/S0140-6736(22)01018-2
pubmed: 36115367
Ohayon MM, Reynolds CF 3rd, Dauvilliers Y. Excessive sleep duration and quality of life. Ann Neurol. 2013;73:785–94.
doi: 10.1002/ana.23818
pubmed: 23846792
pmcid: 4142503
Bastien CH, Vallières A, Morin CM. Validation of the Insomnia Severity Index as an outcome measure for insomnia research. Sleep Med. 2001;2:297–307.
doi: 10.1016/S1389-9457(00)00065-4
pubmed: 11438246
Chung F, Yegneswaran B, Liao P, Chung SA, Vairavanathan S, Islam S, et al. STOP questionnaire: a tool to screen patients for obstructive sleep apnea. Anesthesiology. 2008;108:812–21.
doi: 10.1097/ALN.0b013e31816d83e4
pubmed: 18431116
El Meouchy P, Wahoud M, Allam S, Chedid R, Karam W, Karam S. Hypertension related to obesity: pathogenesis, characteristics and factors for control. Int J Mol Sci. 2022;23:12305.
doi: 10.3390/ijms232012305
pubmed: 36293177
pmcid: 9604511
Kahn SE, Hull RL, Utzschneider KM. Mechanisms linking obesity to insulin resistance and type 2 diabetes. Nature. 2006;444:840–6.
doi: 10.1038/nature05482
pubmed: 17167471
Lanoye A, Adams E, Fuemmeler BF. Obesity and attention-deficit hyperactivity disorder. Curr Top Behav Neurosci. 2022;57:221–41.
doi: 10.1007/7854_2022_337
pubmed: 35505058
Jokela M, Laakasuo M. Obesity as a causal risk factor for depression: systematic review and meta-analysis of Mendelian Randomization studies and implications for population mental health. J Psychiatr Res. 2023;163:86–92.
doi: 10.1016/j.jpsychires.2023.05.034
pubmed: 37207436
Christoffersson G, Vågesjö E, Pettersson US, Massena S, Nilsson EK, Broman JE, et al. Acute sleep deprivation in healthy young men: impact on population diversity and function of circulating neutrophils. Brain Behav Immun. 2014;41:162–72.
doi: 10.1016/j.bbi.2014.05.010
pubmed: 24878171
Lau H, Khosrawipour T, Kocbach P, Ichii H, Bania J, Khosrawipour V. Evaluating the massive underreporting and undertesting of COVID-19 cases in multiple global epicenters. Pulmonology. 2021;27:110–5.
doi: 10.1016/j.pulmoe.2020.05.015
pubmed: 32540223
Fischer A, Badier N, Zhang L, Elbéji A, Wilmes P, Oustric P, et al. Long COVID classification: findings from a clustering analysis in the predi-COVID cohort study. Int J Environ Res Public Health. 2022;19:16018.
doi: 10.3390/ijerph192316018
pubmed: 36498091
pmcid: 9740149
Besedovsky L, Lange T, Haack M. The sleep-immune crosstalk in health and disease. Physiol Rev. 2019;99:1325–180.
doi: 10.1152/physrev.00010.2018
pubmed: 30920354
pmcid: 6689741